cetirizine OTC
Selected indexed studies
- OTC drugs for seasonal allergies. (Med Lett Drugs Ther, 2019) [PMID:31169808]
- In brief: OTC alcaftadine (Lastacaft Once Daily Relief) for allergic conjunctivitis. (Med Lett Drugs Ther, 2022) [PMID:35536123]
- Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review. (World Allergy Organ J, 2022) [PMID:35833202]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- OTC drugs for seasonal allergies. (2019) pubmed
- In brief: OTC alcaftadine (Lastacaft Once Daily Relief) for allergic conjunctivitis. (2022) pubmed
- Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review. (2022) pubmed
- OTC product: Zyrtec and Zyrtec-D 12 hour. (2008) pubmed
- Nonprescription medications for respiratory symptoms: Facts and marketing fictions. (2018) pubmed
- The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis--a meta-analysis. (2011) pubmed
- COVID-19 self-medication treatment: Media's adverse effect based on people's level of education. (2023) pubmed
- Therapeutic advantages of third generation antihistamines. (1998) pubmed
- Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability. (2006) pubmed
- Cost and utilization impacts of oral antihistamines in the California Medi-Cal program. (2005) pubmed